Literature DB >> 22101694

Action mechanisms of complementary and alternative medicine therapies for rheumatoid arthritis.

Imada Keisuke1, Bao-lin Bian, Xiang-dong Li, Sato Takashi, Ito Akira.   

Abstract

Rheumatoid arthritis (RA) is characterized as a chronic inflammatory disease in joints and concomitant destruction of cartilage and bone. Cartilage extracellular matrix components, such as type II collagen and aggrecan are enzymatically degraded by matrix metalloproteinases (MMPs) and aggrecanases in RA. Currently, treatments targeting cytokines, including anti-tumor necrosis factor (TNF) α antibodies, soluble TNF receptor, anti-interleukin (IL)-6 receptor antibody, and IL-1 receptor antagonist, are widely used for treating RA in addition to antiantiinflammatory agents and disease-modifying antirheumatic drugs (DMARDs), such as inflmethotrexate, but these treatments have some problems, especially in terms of cost and the increased susceptibility of patients to infection in addition to the existence of low-responders to these treatments. Therefore, therapeutics that can be safely used for an extended period of time would be preferable. Complementary and alternative medicines including traditional Chinese medicines (TCM) have been used for the arthritic diseases through the ages. Recently, there are many reports concerning the anti-arthritic action mechanisms of TCM-based herbal formulas and crude herbal extracts or isolated ingredients. These natural herbal medicines are thought to moderately improve RA, but they exert various actions for the treatment of RA. In this review, the current status of the mechanism exploration of natural compounds and TCM-based herbal formulas are summarized, focusing on the protection of cartilage destruction in arthritic diseases including RA and osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22101694     DOI: 10.1007/s11655-011-0871-3

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  77 in total

Review 1.  Symptomatic slow-acting drugs for osteoarthritis: what are the facts?

Authors:  Maxime Dougados
Journal:  Joint Bone Spine       Date:  2006-10-11       Impact factor: 4.929

2.  Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.

Authors:  M W Lark; E K Bayne; J Flanagan; C F Harper; L A Hoerrner; N I Hutchinson; I I Singer; S A Donatelli; J R Weidner; H R Williams; R A Mumford; L S Lohmander
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

Review 3.  Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?

Authors:  Gillian Murphy; Hideaki Nagase
Journal:  Nat Clin Pract Rheumatol       Date:  2008-03

4.  Triptolide is more effective in preventing T cell proliferation and interferon-gamma production than is FK506.

Authors:  M A Chan; J E Kohlmeier; M Branden; M Jung; S H Benedict
Journal:  Phytother Res       Date:  1999-09       Impact factor: 5.878

5.  Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription.

Authors:  B Wang; L Ma; X Tao; P E Lipsky
Journal:  Arthritis Rheum       Date:  2004-09

6.  Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages.

Authors:  Na Lin; Takashi Sato; Yuji Takayama; Yoshihiro Mimaki; Yutaka Sashida; Masamichi Yano; Akira Ito
Journal:  Biochem Pharmacol       Date:  2003-06-15       Impact factor: 5.858

7.  Selective inhibition of ADAMTS-1, -4 and -5 by catechin gallate esters.

Authors:  Mireille N Vankemmelbeke; Gavin C Jones; Cyprianne Fowles; Mirna Z Ilic; Christopher J Handley; Anthony J Day; C Graham Knight; John S Mort; David J Buttle
Journal:  Eur J Biochem       Date:  2003-06

Review 8.  Collagens--major component of the physiological cartilage matrix, major target of cartilage degeneration, major tool in cartilage repair.

Authors:  T Aigner; J Stöve
Journal:  Adv Drug Deliv Rev       Date:  2003-11-28       Impact factor: 15.470

Review 9.  Aggrecanases and cartilage matrix degradation.

Authors:  Hideaki Nagase; Masahide Kashiwagi
Journal:  Arthritis Res Ther       Date:  2003-02-14       Impact factor: 5.156

10.  Triptolide, an active compound identified in a traditional Chinese herb, induces apoptosis of rheumatoid synovial fibroblasts.

Authors:  Natsuko Kusunoki; Ryuta Yamazaki; Hidero Kitasato; Moroe Beppu; Haruhito Aoki; Shinichi Kawai
Journal:  BMC Pharmacol       Date:  2004-02-17
View more
  2 in total

1.  Chondroprotective and anti-inflammatory effects of ChondroT, a new complex herbal medication.

Authors:  Jung Up Park; Seon-Jong Kim; Chang-Su Na; Chan-Hun Choi; Chang Seob Seo; Jong-Keun Son; Bok Yun Kang; Young Ran Kim
Journal:  BMC Complement Altern Med       Date:  2016-07-13       Impact factor: 3.659

2.  Ganghwaljetongyeum, an anti-arthritic remedy, attenuates synoviocyte proliferation and reduces the production of proinflammatory mediators in macrophages: the therapeutic effect of GHJTY on rheumatoid arthritis.

Authors:  Bo-Ram Jeoung; Kyung Dong Lee; Chang-Su Na; Young-Eok Kim; BoA Kim; Young Ran Kim
Journal:  BMC Complement Altern Med       Date:  2013-02-26       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.